logo

EVIDENCE • EXPERIENCE • OUTCOMES

INTELLIGENCE BYMDReviewer
Home
About
Contact
Back
  • No Preview Available

CADENCE ICD SYSTEM

Write a review
Generic:Pulse generator, permanent, implantable
Manufacturer:abbott medical
Drug Classes:Not Available
Reps:
Rep 1Signup or Login to view Reps
Rep 2Signup or Login to view Reps
  • No Preview Available

CADENCE ICD SYSTEM

Generic:Pulse generator, permanent, implantable
Manufacturer:abbott medical
Drug Classes:Not Available
Reps:
Rep 1Signup or Login to view Reps
Rep 2Signup or Login to view Reps
šŸ‘‹

No reviews yet — be the first!

100% anonymous Ā· Verified U.S. prescribers only

(no name, NPI, or practice ever shown)
Synopsis
Contents
DescriptionIndication and Usage
Similar Products
Synopsis
Generated with AlphaAI.MD
Product:
CADENCE ICD SYSTEM
Category:
Indication:
Mechanism:
Safety:
Dosing:
Patient:
Reviews:
No reviews yet
see more
Disclaimer: The synopsis and product information provided on Alpha.MD are derived from openFDA data and are for informational purposes only. This information may not be comprehensive, accurate, or up-to-date. Clinicians should exercise their own professional judgment in interpreting and using this information, and consult the official prescribing information for the most accurate and current details.
Description

An implantable pacemaker pulse generator is a device that has a power supply and electronic circuits that produce a periodic electrical pulse to stimulate the heart. This device is used as a substitute for the heart's intrinsic pacing system to correct both intermittent and continuous cardiac rhythm disorders. This device may include triggered, inhibited, and asynchronous modes and is implanted in the human body.

Indication and Usage

This device is indicated for use in patients with a history of hemodynamically compromising ventricular tachyarrhythmias. These patients may have experienced a cardiac arrest not associated with acute myocardial infarction or have ventricular tacharrhythmias. In addition, the CadenceĀ® can be used in patients whose primary therapy for hemodynamically significant, sustained ventricular tachycardia is antitachycardia pacing; the defibrillation capabilities of the device provide high energy therapy in the event that the arrhythmia accelerates. The CadenceĀ® is intended for use with the defibrillation lead systems with which it has been tested: Ventritex epicardial defibrillation leads, and commercially available CPI defibrillation patch leads and superior vena cava (SVC) spring leads. When used with the CPI patch lead or SVC leads, the CadenceĀ® is intended for use as a replacement for CPI automatic implantable cardioverter defibrillators.

Approval History
FDA approved 2009
Includes history for all formulations of adalimumab
April 28, 2009
(Type 2 New Active Ingredient and Type 4 New Combination)
Frequently Asked Questions
How much does Humira cost without insurance?
J
John Doe
New York, US
Products:

Humira

Humira

J
John Doe
New York, US
Products:

Humira

Humira

Signup or Login to view Reps
You must have an account to view Reps detail
Already have an account? Login
There isn't any reviews posted yet. You can be the first to review the product